In this report, we describe an investigation of the effects of Lutzomyia longipalpis sand fly salivary gland homogenates (SGH) on cytokine production and expression of costimulatory molecules on human monocytes, macrophages (Ms), and dendritic cells (DCs). SGH of L. longipalpis induced an increase in interleukin-6 (IL-6), IL-8 and IL-12p40 production but a decrease in tumor necrosis factor alpha and IL-10 production by lipopolysaccharida (LPS)-stimulated monocytes. We also examined the expression of costimulatory molecules on the surface of monocytes, Ms, and DCs. Whereas SGH affected the expression of these molecules on monocytes and Ms, it had little effect on these molecules on DCs. However, when DCs were generated from human monocytes in the presence of SGH, SGH inhibited the expression of costimulatory molecules. In addition, a decrease in the maturation of DCs induced by CD40L was observed in the presence of SGH. Finally, preincubating SGH with human sera containing anti-SGH-specific antibodies abolished the effects of SGH on cytokine production by LPS-stimulated monocytes.
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Members of the genus Leishmania are sand fly vector-transmitted protozoan parasites that cause leishmaniasis in the mammalian host. Within the mammalian host, Leishmania resides in phagocytic cells such as monocytes, Ms, and DCs. Cell-mediated immunity is essential for resistance to the parasite. In the experimental-mouse model of infection, it has been found in general that type 1 T-cell responses (and the gamma interferon [IFN-␥], interleukin-12 , tumor necrosis factor alpha [TNF-␣], and inducible nitric oxide synthase [iNOS] or NO associated with them) are protective whereas type 2 T-cell responses (and the IL-4, IL-5, and IL-6 associated with them) exacerbate disease (reviewed in references 12, 21, and 35).
Sand flies inject the mammalian host with Leishmania in saliva. The saliva of blood-feeding arthropods contains a wide variety of molecules that modulate their hosts' hemostatic, inflammatory, and immune responses (39) . When Lutzomyia longipalpis or Phlebotomus papatasi sand fly SGH were mixed with Leishmania major and injected into mice, the resulting cutaneous lesions were significantly larger than those seen on mice injected with L. major alone (5, 37, 38, 40, 44) . To define the mechanism underlying this phenomenon, the effects of SGH on various immune functions were examined. SGH, whose components may have unique, synergistic, or antagonistic activities, have been reported to affect iNOS activity, the Th1-Th2 balance, and the persistence of neutrophils and eosinophils at sites of Leishmania infection (10, 20, 28, 29, 43) . In addition, injecting sand fly saliva into normal but not scid mice induced IL-4 production at the dermis and in draining lymph nodes (5, 25) . It has been suggested that SGH acts at the level of APCs rather than exerting a direct effect on T cells. Sand fly saliva affects APCs by decreasing antigen presentation, NO production, and Leishmania killing (15, 38) . Maxadilan, the vasodilator of L. longipalpis salivary glands, also has potent immunosuppressive properties that lead to induction of IL-10 and IL-6 but inhibition of TNF-␣ production (7, 34) . Taken together, these observations indicate that sand fly saliva modifies the early inflammatory response of the host to a phenotype permissive for infection with Leishmania.
In striking contrast to the results seen in sand fly saliva-naive mice, the disease-exacerbating effects of saliva were abolished in mice preexposed to saliva or the bites of noninfected sand flies. This was associated with a strong inflammatory response and with the production of IL-12 and IFN-␥ at the site of inoculation (5, 18, 19) . Furthermore, immunization of mice against a single component of saliva (a molecule of 15 kDa) also blunted the disease-enhancing effects of saliva. This was also true in B-cell-deficient mice, indicating that a cell-mediated inflammatory response to saliva provided most if not all the protective effects of this vaccine (42) .
When sand flies feed on humans, they lacerate capillaries, forming a hemorrhagic pool of blood (29, 33) . This creates a microenvironment where monocytes, Ms, and DCs, among other cells, are exposed to salivary components injected by the sand flies. Little is known about the effects of sand fly saliva on human cells; however, evidence suggests that such interactions occur. Children living in an area where visceral leishmaniasis is endemic developed antibodies against components of L. longipalpis saliva (3), and this response was concurrent with the development of an anti-Leishmania response (14) . Additionally, anti-Leishmania immune responses differed between groups of children who mount or do not mount an anti-sand fly saliva response (14) , suggesting that sand fly saliva modifies the immune response to Leishmania in humans as it does in mice.
In order to explore the effects of SGH from L. longipalpis on the human immune response, we examined the effects of SGH on the expression of surface molecules (e.g., CD80 and CD86) important in the development of an immune response, as well as cytokine (e.g., interleukin) production by human monocytes, Ms, or DCs treated with SGH and stimulated or not stimulated with LPS. Understanding how salivary products interfere with LPS-induced costimulatory molecule expression and cytokine production will help clarify the complex interactions that occur between sand fly saliva, Leishmania, and the human host when the host is infected with the parasite. Becton Dickinson, San Diego, Calif.), using anti-CD14 and HLA-DR antibodies conjugated to PE or FITC as well as isotype controls. The remaining cells (10 6 ) were cultured in RPMI 1640 medium supplemented with 2mM L-glutamine, penicillin (100 U/ml), gentamicin (100 g/ml), and 10% heat-inactivated fetal bovine serum (HyClone, Ogden, Utah), termed complete medium. These cells were pretreated with SGH (0.5 pair of glands/ml) overnight and then incubated with LPS of E. coli serotype O11:B4 (Sigma-Aldrich) (30 pg/ml) for 24 or 48 h. The cultured cells and/or culture supernatants were harvested 24 or 48 h later. The cells were analyzed by flow cytometry to characterize cell surface molecule expression (CD80, CD86, HLA-DR, and CD14). The supernatants were kept at Ϫ20°C until tested for cytokine content by ELISA.
MATERIALS AND METHODS

Abbreviations
Human Ms were obtained from human PBMC. PBMC were placed in 24-well plates (Costar, Corning, Corning, N.Y.) at a concentration of 5 ϫ 10 6 cells/ ml and incubated for 30 min at 37°C at 5% CO 2 . Nonadherent cells were removed from the plates, and adherent cells were cultured in complete medium for 7 days. The cells were pretreated with SGH (0.5 pair of glands/ml) overnight and stimulated with LPS for 24 or 48 h. Cells or culture supernatants were then harvested and analyzed by flow cytometry or by ELISA as described above.
Human DCs were generated from PBMC as previously described (32) . Briefly, monocytes were obtained as detailed above and 3 ϫ 10 5 /ml cells were cultured at 37°C, under 5% CO 2 in air, in RPMI 1640 medium plus 10% fetal bovine serum supplemented with granulocyte-M colony-stimulating factor (50ng/ml) and IL-4 (1,000 U/ml). Portions (300 ml) medium and cytokines were replaced every 3 days. DCs were used after 8 days of culture. The cells were characterized by flow cytometry using antibodies against CD1a, CD14, CD80, CD86, HLA-DR, and CD83 conjugated to PE or FITC, as well as isotype controls. These cells were pretreated with SGH (1.0 pair of glands/ml) and stimulated with LPS (200 pg/ml) or CD40L (Ancell, Bayport, Minn.) at 2 g/ml for 24 or 48 h. In some experiments, DCs were generated in the presence of SGH (1.0 pair of glands/ml). Cells were harvested to be analyzed by flow cytometry to determine their surface molecule expression, and supernatants were tested for cytokine content by ELISA.
Sand flies and preparation of SGH: L. longipalpis sand flies were reared at Centro de Pesquisa Gonçalo Moniz, FIOCRUZ, as described elsewhere (26) . Adult sand flies had free access to a 10% solution of sucrose. Salivary glands from 5-to 7-day old adult female flies were dissected and transferred to polypropylene vials, usually in groups of 20 pairs of glands in 20 l of HEPES-saline. Salivary glands were kept at Ϫ75°C until needed, when they were disrupted by sonication using a Sonifier 450 homogenizer (Branson, Danbury, Conn.) (30) . The SGH were centrifuged at 10,000 ϫ g for 2 min, and the supernatants were then used for experiments.
Flow cytometry. Cells (5 ϫ 10 5 ) were resuspended in PAB (phosphate-buffered saline, 1% bovine serum albumin, 0.05% sodium azide) and blocked with 20% fetal bovine serum and Fc block (20 g/ml of mouse Ig) for 30 min on ice. They cells were then labeled with monoclonal antibodies or respective controls for an additional 30 min. They were fixed with 1% paraformaldehyde in phosphate-buffered saline and analyzed by flow cytometry. We used the following antibodies (from Becton Dickinson) in these experiments PE-or FITC-labeled anti-human CD80 (clone L307.4, mouse IgG1); PE-or FITC-labeled anti-human CD86 (clone 233, FUN-1 mouse IgG1); cyanine-labeled anti-human CD40 (clone 5C-3, mouse IgG1); PE-labeled anti-human CD83 (clones HB15e); FITClabeled anti-human HLA DR, DP, and DQ (clone TU 39, mouse IgG2a); PE-, FITC-or Cy-labeled mouse IgG1, chain (clone MOPC-21, isotype control); and FITC-labeled mouse IgG2a, chain (clone MOPC-173, isotype control).
Cytokine assays. Levels of TNF-␣, IL-6, IL-8, IL-10, and IL-12p40 in supernatants were determined by ELISA using commercial anti-cytokine antibody pairs (Becton Dickinson) as specified by the manufacturer. Human recombinant TNF-␣, IL-6, IL-8, IL-10, and IL-12p40 (Pharmingen) were used to generate standard curves. Human sera. Young healthy adults from areas where leishmaniasis was not endemic, with negative serology to sand fly saliva and normal IgE levels, were accepted in our study so that we could obtain human sera containing high levels of antibodies to L. longipalpis saliva. These individuals underwent repeated experimental exposures to L. longipalpis bites, with sequential evaluation of their humoral immunity against the vector saliva. Individuals were exposed to 20 phlebotomines four times at 15-day intervals. All individuals participated in this study after informed consent was obtained, and the Committee of Ethics of Centro de Pesquisa Gonçalo Moniz approved this study. These sera showed high levels of IgG anti-L. longipalpis saliva antibodies. We also used human sera from normal volunteers who were not exposed to L. longipalpis as controls of the experiments.
Statistical analysis. Comparison of cytokine levels in the presence or absence of SGH was done by a nonparametric Wilcoxon test. All tests were performed using Prism software (GraphPad Software, Inc., San Diego, Calif.). Differences were considered significant if P Ͻ 0.05.
RESULTS
SGH affects cytokine production by LPS-stimulated human monocytes. We first investigated whether L. longipalpis sand fly SGH would affect cytokine production by LPS-treated human monocytes. Monocytes were pretreated with SGH (0.5 pair of glands/ml) overnight and then treated with LPS. SGH significantly decreased LPS-induced TNF-␣ and IL-10 secretion by monocytes (Fig. 1A and B) . Conversely, we observed a significant increase in the levels of IL-6, IL-8, and IL-12p40 production by LPS-stimulated monocytes (Fig. 1C to E) .
We also tested the effects of SGH on human Ms and DCs. SGH had no significant effect on the LPS-induced secretion of TNF-␣, IL-10, or IL-12 p40 by either cell type (data not shown).
Effects of SGH on the expression of costimulatory molecules on human monocytes and Ms. Since costimulatory molecules play an essential role in the activation and maintenance of T-cell responses, we analyzed the expression of CD80, CD86, CD40, and HLA-DR on SGH pretreated monocytes and Ms. SGH decreased the expression of CD80 on the surface of LPSstimulated monocytes and Ms ( Fig. 2A and D) . On the other hand, SGH enhanced the expression of CD86 and HLA-DR but not of CD40 (data not shown) on the surface of LPSstimulated monocytes (Fig. 2B and C) . On Ms, there was an increase in HLA-DR expression (Fig. 2F ) but no alteration in CD86 expression (Fig. 2E) . This effect was due to increased mean fluorescence intensity, not an increase in the percentage of positive cells. Effect of SGH on DC maturation induced by CD40L stimulation. Next we analyzed the effect of SGH on DC maturation. No effect was seen when we stimulated DCs with LPS (200 pg/ml) in the presence or absence of SGH (data not shown). However, when we stimulated DCs with CD40L in the presence of SGH, we observed a decrease in the expression of CD80, CD86, and HLA-DR (Fig. 4) .
SGH inhibits the expression of costimulatory molecules on human DCs if SGH is included in cultures in
Anti-SGH antibodies neutralize the effects of SGH on LPSstimulated monocytes. Pretreating SGH with immune serum abrogated both the inhibitory and stimulatory effects of SGH on LPS-stimulated human monocytes. Whereas SGH alone led to decreased production of TNF-␣ and IL-10, immune serumpretreated samples exhibited levels similar to those in cultures without saliva (Fig. 5A and D) . On the other hand, while SGH led to increased production of IL-6 and IL-12 p40, these effects disappeared when SGH was pretreated with immune serum (Fig. 5B and C) . As controls, we pretreated SGH with normal human sera without anti-saliva antibodies. We did not observe any significant differences between this group and that treated with SGH plus LPS (data no shown).
DISCUSSION
It is now clear that saliva of many different arthropod vectors of disease, including sand flies (18) , contains immunomodulatory molecules that can affect the immune response at several levels (13) . Moreover, it has been shown with both Old World (P. papatasi) and New World (L. longipalpis) sand flies that saliva can dramatically enhance infection by several species of Leishmania (13, 18) . It has been suggested that the molecule in L. longipalpis saliva that enhances infection is the vasodilator/ immunomodulator maxadilan, since maxadilan alone can enhance infection with L. major to the same degree as whole saliva can (27) .
Most of the work with sand fly saliva has utilized experimental animals (principally mice). A common finding in this experimental-mouse work is that sand fly saliva inhibits TNF-␣ production while it augments the secretion of IL-6 (34). Since comparatively little work has been done examining the effects of sand fly saliva on human cells, we examined the effects of SGH on human monocytes, Ms, and DCs with respect to cytokine secretion and expression of surface molecules important in the development of an immune response. We show that L. longipalpis SGH augments IL-6, IL-8, and IL-12p40 production while it inhibits TNF-␣ and IL-10 production by human monocytes (Fig. 1) . The intensity of the stimulatory or inhibitory effects was distinct among different donors and was negligible in some of them. Considering the variation of the human population, the dispersion observed in our results is not unexpected and in fact has been observed and reported in many publications dealing with studies of humans.
In the mouse model of leishmaniasis, the proinflammatory cytokine TNF-␣ has been examined extensively because of its potential effector function. Treatment with TNF-␣ results in a reduction of the lesion size and parasitic burden (22, 23, 41) . In addition, treatment with a neutralizing anti-TNF-␣ antibody leads to a transient aggravation of the disease (9, 37, 41). Recently, it has been shown that resistant C57BL/6 mice that lack the TNF-␣ gene developed visceral leishmaniasis when infected with L. major, which led to rapid death of the animals (45) .
IL-6 is a cytokine synthesized by T cells and Ms. It has pleiotropic effects on diverse cell types and is recognized for its proinflammatory properties (17) . Pretreatment of human Ms with IL-6 induced a dose-and time-dependent suppression of IFN-␥ and TNF-␣ activation of Ms and thus induced inhibition of killing of Leishmania amazonensis (16) . IL-6 alone had no effect on M viability or intracellular L. amazonensis growth, but it down modulated the ability of TNF-␣ to enhance the oxidative capacity of treated Ms and thus the ability of the Ms to kill the parasite. The data presented here show that SGH down regulates TNF-␣ but enhances IL-6 production by human monocytes (Fig. 1) . Therefore, through its ability to modify components of the innate immune response (TNF-␣ and IL-6), sand fly saliva may enhance the survival of Leishmania in humans infected with the parasite.
L. longipalpis SGH also augmented IL-8 secretion by human monocytes (Fig. 1) . Interestingly, Leishmania parasites also the augment production of IL-8 by human monocytes (2) . IL-8 is strongly chemotactic for neutrophils, and neutrophils are plentiful in early cutaneous lesions of Leishmania. It is unknown how an increase in the influx of neutrophils into leishmanial lesions might affect the evolution of those lesions. Neutrophils can engulf Leishmania, but they are very short-lived cells. However, it has recently been reported (1) that infecting neutrophils with L. major prevented the cells from apoptosis, substantially extending the lifetime of the cells and hence survival of the parasite within the cells.
Finally, we found that L. longipalpis SGH augmented IL12p40 synthesis while inhibiting IL-10 secretion by human monocytes (Fig. 1) . IL-12 is known to be critical for the development of cell-mediated/Th1 T-cell responses. Indeed, IL-12 positively regulates the production of IFN-␥ while IL-10 negatively regulates it; thus, the three cytokines closely regulate each other's production (4, 27, 34) . Since SGH augments IL-12 but inhibits IL-10, this suggests that components of SGH may promote the development of a cell-mediated response. In fact, it has been known for decades that the saliva of Old World P. papatasi sand flies can induce DTH responses in humans (a condition known as harara [36] ). It has been proposed that a DTH response to saliva might be beneficial to the sand fly since blood flow at DTH sites is enhanced and thus the sand fly can complete its blood meal more rapidly (6) . Although a New World counterpart of harara has not been reported, it is possible that such a clinical condition exists. More work is required to determine whether New World sand fly saliva can induce DTH responses to itself.
It should be mentioned that maxadilan, the immunomodulator from L. longipalpis salivary glands, has been reported to have some of the same effects (e.g., the ability to inhibit TNF-␣ but enhance IL-6 secretion) on both mouse (34) and human (31) cells. However, maxadilan does not enhance IL-12p40 secretion; rather, it inhibits the production of both IL-12p40 and IFN-␥ by human PBMC treated with maxadilan and infected with L. major (31) . Although the two systems are not FIG. 5 . Neutralization of the effects by of SGH by human sera that contain anti-salivary antibodies. Monocytes were obtained from PBMC and were stimulated with LPS (30 pg/ml) or pretreated with SGH overnight and stimulated with LPS (30 pg/ml). In addition, in some cultures, SGH was first incubated with human sera for 40 min at 37°C. This treated SGH was then incubated with monocytes overnight, and the cells were stimulated with LPS. At 24 or 48 h later, the supernatants of the cultures were harvested and tested for their content of the indicated cytokines by ELISA. (A) TNF-␣; (B) IL-6; (C) IL-12p40; (D) IL-10. The white bars represent cytokine production by cells stimulated with LPS alone; the black bars represent cytokine production in the presence of SGH, and the gray bars represent cytokine production when the SGH was preincubated with the antiserum and this mixture was used to pretreat the cells followed by stimulation with LPS. The data shown are from four independent experiments, and standard errors are indicated. As controls, SGH were pretreated with normal human sera (without anti-saliva antibodies), and no significant differences were observed between this group and that treated with SGH plus LPS (data not shown). We also examined the effects of SGH on the expression of cell surface molecules on APCs that are important to the development of an immune response. In leishmaniasis these molecules are critical for the development of a protective Tcell response. For instance, class II MHC molecules are required for the activation of CD4 T cells and protection against infection with L. major (24) . Moreover, costimulatory molecules (e.g., CD80 and CD86) also influence the immune response to L. major (8, 11) . Thus, changes in the expression of MHC class II, CD80 or CD86 can alter the T-cell response. SGH influenced the expression of all of these molecules on the three APC types examined; monocytes, Ms, and DCs. Perhaps the most striking effect was the ability of SGH to enhance HLA-DR expression ( Fig. 2C and F) .
Finally, we have recently reported that anti-sand fly salivary antibodies develop in the serum of Brazilian children living in areas where leishmaniasis is endemic. The appearance of these antibodies was correlated with the development of anti-leishmanial DTH. That is, it appeared that anti-sand fly salivary gland immunity (which presumably would neutralize the immunomodulatory effects of sand fly saliva) allows the host to develop protective immunity against Leishmania (14) . To directly test this hypothesis that the anti-saliva antibodies could neutralize the immunomodulatory properties of saliva, we tested whether the antisera would block the ability of SGH to modulate cytokine responses. In all cases tested (Fig. 5) , the effects of SGH were blocked.
The data presented here represent the first report that SGH from L. longipalpis sand flies affects the phenotype and functions of cells of the human immune system. This is important information since although it is clear from work with experimental animals that sand fly saliva can affect the immune response and that targeting components of the salivary glands can protect against leishmaniasis (13, 18, 27, 42) , little is known about the effect of sand fly saliva on human cells and thus whether a sand fly-based vaccine would protect humans. The data showing that sera from humans who live in areas where leishmaniasis is endemic can neutralize the immunomodulatory effects of saliva are particularly encouraging. These data suggest that humans can develop antibodies that block the effects of saliva and that an appropriate vaccine should accelerate the development of these antibodies in the vaccinated host and thus protect against leishmaniasis. As to what target should be used for this vaccine, it has been shown that maxadilan in L. longipalpis saliva can protect mice from infection with Leishmania (27) . However, the data presented here suggest that there may be another immunomodulator in L. longipalpis saliva that promotes the secretion of IL-12p40 and inhibits IL-10 synthesis (Fig. 1) . Since humans can generate antibodies that can block the IL-12-enhancing effect of saliva (Fig. 5) , it would be interesting to find which molecule(s) is responsible for IL-12 enhancement. Such a molecule(s) might be another vaccine target since it would be predicted to inherently stimulate the development of a Th1 response, which is protective in leishmanial infections. Moreover, since humans naturally produce antibodies to the IL-12 enhancer, individuals who receive this vaccine would be naturally boosted when they are bitten by sand flies.
